Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-13-065520
Filing Date
2013-12-04
Accepted
2013-12-04 14:59:33
Documents
1
Period of Report
2013-11-27

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v362216_4.html 4  
1 OWNERSHIP DOCUMENT v362216_4.xml 4 6815
  Complete submission text file 0001144204-13-065520.txt   8319
Mailing Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077
Business Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077 310-474-9809
Targeted Medical Pharma, Inc. (Issuer) CIK: 0001420030 (see all company filings)

EIN.: 205863618 | Fiscal Year End: 1209
SIC: 2834 Pharmaceutical Preparations

Mailing Address TARGETED MEDICAL PHARMA, INC. 2980 BEVERLY GLEN CIRCLE, SUITE 301 LOS ANGELES CA 90077
Business Address
Giffoni Kim (Reporting) CIK: 0001509563 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-53071 | Film No.: 131256920